Kyung Nam Pharm Co Ltd (053950)

Currency in KRW
639
+4(+0.63%)
Closed·
053950 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 10 days
053950 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
630640
52 wk Range
5401,098
Key Statistics
Bid/Ask
637.00 / 639.00
Prev. Close
635
Open
635
Day's Range
630-640
52 wk Range
540-1,098
Volume
96.58K
Average Volume (3m)
247.97K
1-Year Change
-36.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
053950 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Kyung Nam Pharm Co Ltd Company Profile

Kyung Nam Pharm Co.,Ltd. engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia. It also offers electronic, and agricultural and livestock products. The company was formerly known as HS Bio Pharm Co., Ltd. and changed its name to Kyung Nam Pharm Co.,Ltd. in May 2010. Kyung Nam Pharm Co.,Ltd. was founded in 1993 and is headquartered in Uiryeong, South Korea.

Employees
243

Compare 053950 to Peers and Sector

Metrics to compare
053950
Peers
Sector
Relationship
P/E Ratio
−16.0x7.4x−0.5x
PEG Ratio
−0.130.020.00
Price/Book
0.4x0.9x2.6x
Price / LTM Sales
0.9x0.8x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock17.5%6.8%Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-20.00 / --
Revenue / Forecast
13.09B / --
EPS Revisions
Last 90 days

053950 Income Statement

FAQ

What Stock Exchange Does Kyung Nam Pharm Trade On?

Kyung Nam Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Kyung Nam Pharm?

The stock symbol for Kyung Nam Pharm is "053950."

What Is the Kyung Nam Pharm Market Cap?

As of today, Kyung Nam Pharm market cap is 49.94B.

What Is Kyung Nam Pharm's Earnings Per Share (TTM)?

The Kyung Nam Pharm EPS (TTM) is -57.55.

When Is the Next Kyung Nam Pharm Earnings Date?

Kyung Nam Pharm will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is 053950 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kyung Nam Pharm Stock Split?

Kyung Nam Pharm has split 2 times.

How Many Employees Does Kyung Nam Pharm Have?

Kyung Nam Pharm has 243 employees.

What is the current trading status of Kyung Nam Pharm (053950)?

As of 09 Aug 2025, Kyung Nam Pharm (053950) is trading at a price of 639.00, with a previous close of 635.00. The stock has fluctuated within a day range of 630.00 to 640.00, while its 52-week range spans from 540.00 to 1,098.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.